These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 27083371

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chitosan oligosaccharide based Gd-DTPA complex as a potential bimodal magnetic resonance imaging contrast agent.
    Huang Y, Cao J, Zhang Q, Lu ZR, Hua MQ, Zhang XY, Gao H.
    Magn Reson Imaging; 2016 Jan; 34(1):1-7. PubMed ID: 26485295
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
    Guo YM, Liu M, Yang JL, Guo XJ, Wang SC, Duan XY, Wang P.
    Chin Med J (Engl); 2007 Jan 05; 120(1):50-5. PubMed ID: 17254488
    [Abstract] [Full Text] [Related]

  • 7. Facile Synthesis of Gadolinium Chelate-Conjugated Polymer Nanoparticles for Fluorescence/Magnetic Resonance Dual-Modal Imaging.
    Pan Y, Chen W, Yang J, Zheng J, Yang M, Yi C.
    Anal Chem; 2018 Feb 06; 90(3):1992-2000. PubMed ID: 29293314
    [Abstract] [Full Text] [Related]

  • 8. Improving the MR Imaging Sensitivity of Upconversion Nanoparticles by an Internal and External Incorporation of the Gd(3+) Strategy for in Vivo Tumor-Targeted Imaging.
    Du H, Yu J, Guo D, Yang W, Wang J, Zhang B.
    Langmuir; 2016 Feb 02; 32(4):1155-65. PubMed ID: 26740341
    [Abstract] [Full Text] [Related]

  • 9. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
    Unger EC, Shen D, Wu G, Stewart L, Matsunaga TO, Trouard TP.
    MAGMA; 1999 Aug 02; 8(3):154-62. PubMed ID: 10504042
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of Gd(III) porphyrin-conjugated chitosan nanoparticles as contrast agents for magnetic resonance imaging.
    Jahanbin T, Sauriat-Dorizon H, Spearman P, Benderbous S, Korri-Youssoufi H.
    Mater Sci Eng C Mater Biol Appl; 2015 Aug 02; 52():325-32. PubMed ID: 25953574
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
    Parac-Vogt TN, Kimpe K, Laurent S, Vander Elst L, Burtea C, Chen F, Muller RN, Ni Y, Verbruggen A, Binnemans K.
    Chemistry; 2005 May 06; 11(10):3077-86. PubMed ID: 15776492
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gd(III) complexes intercalated into hydroxy double salts as potential MRI contrast agents.
    Jin M, Spillane DE, Geraldes CF, Williams GR, Bligh SW.
    Dalton Trans; 2015 Dec 21; 44(47):20728-34. PubMed ID: 26568157
    [Abstract] [Full Text] [Related]

  • 20. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
    Khantasup K, Saiviroonporn P, Jarussophon S, Chantima W, Dharakul T.
    MAGMA; 2018 Oct 21; 31(5):633-644. PubMed ID: 29737435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.